Navigation Links
American Oriental Bioengineering Completes Two Acquisitions
Date:10/21/2008

Terminates Prior LOI and Acquires Profitable Holding Company to Strengthen

Distribution Network and Retail Presence Acquires Research and Product Development Company to Expedite Product

Launches

Conference Call Scheduled for October 22, 2008 at 8:00 am E.T.

NEW YORK, Oct. 21 /Xinhua-PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB) ("AOBO"), a leading marketer and manufacturer of pharmaceutical and healthcare products in China, today announced that it has completed the acquisition of Nuo Hua Investment Company Ltd. ("Nuo Hua"), as well as the acquisition of GuangXi HuiKe Research and Development Company Ltd. ("GHK"), in cash transactions totaling $53.1 million. Nuo Hua is a holding company with subsidiaries and affiliated companies that maintain a significant presence in pharmaceutical wholesale and retail distribution in China. AOBO acquired Nuo Hua for $39.5 million after terminating a previously announced, non-binding Letter of Intent to acquire another company in the distribution industry in China, as discussed below. GHK is engaged in pharmaceutical research and product development leading to SFDA approval and expedient product launches in China. The acquired companies are profitable and AOBO believes that the acquisitions will significantly enhance AOBO's distribution platform and product launch capabilities, particularly for new product launches starting in 2009.

Tony Liu, Chief Executive Officer of American Oriental Bioengineering stated, "We are very pleased to acquire Nuo Hua and GHK and today's announcement represents a major step toward achieving our goal of becoming one of China's top pharmaceutical companies. Nuo Hua provi
'/>"/>

SOURCE American Oriental Bioengineering, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
(Date:12/2/2009)HOBOKEN, N.J., Dec. 2 According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopat
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...he Wisconsin Technology Council has teamed with Pr... to provide a searchable database of commercial re...sintechnologycouncil.com. The service can be acce...perty Search. , ,This new feature will allow techn...consin the ability to search a wide variety of spa...
...e of the IT industry news rags was making a big de...r players in radio frequency ID tag manufacture. A...ed that some customers were claiming failure rates... suggesting other factors like poor paper quality ...r was rolled up to tightly. , ,Whatever the cause...
...C. Johnson & Son Inc. made the No. 2 spot in the ...04. The top spot in this year,s list of technology...sconsin organzations, other than S.C. Johnson, mad... maintaining the annual list for the past seven ye...y agendas and usage, and examining their business ...
Other Biology Technology:The more things change ... 2The more things change ... 3S.C. Johnson lands in No. 2 spot in Information Week 500 list 2
(Date:12/3/2009)...Dec. 3, 2009) Van Andel Research Institute (VAR...lant hormone abscisic acid (ABA) works at the mole...l stresses such as drought and cold. Their findin...engineer crops that thrive in harsh environments a... The findings could also have implications for str...
(Date:12/3/2009)...erly upset by a social snubbing? Your genetics, no...e long known that opium-like painkillers, called o...ome forms of emotional stress. Now, a new study re...ilig shows that small genetic differences in the g...nsity of people,s responses to social rejection. ...
(Date:12/3/2009)...have measured CO2 levels for the past three years ...ely inhabited rural area near Valladolid. The resu...ian Peninsula, show that the levels rose "signific..., physicists and meteorologists have been trying t...how these have evolved in the troposphere over var...
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3CO2 levels rising in troposphere over rural areas 2Science Coalition commends Presidents strategy for innovation 10011 1Endometrial Ablation Offers Relief for Abnormally Heavy or Irregular Menstrual Bleeding 57880 1Endometrial Ablation Offers Relief for Abnormally Heavy or Irregular Menstrual Bleeding 57880 2Endometrial Ablation Offers Relief for Abnormally Heavy or Irregular Menstrual Bleeding 57880 3VIDEO from Medialink and Siemens 3A Hi Tech Donation Benefits Childrens Health Fund 57878 1
...genome sequence was published. Now, nearly 200 bac...hits the scientific press most weeks. This burgeon...ing,?however. Having all these genome sequences ma...se human disease, how to control their spread, and...mparing genome sequences, scientists can learn muc...
...of a therapeutic cancer vaccine combining the synt... Coley Pharmaceutical), with a peptide antigen wer...igation. The paper shows that the CpG 7909 DNA seq...bility to recognize and destroy cancer cells. The ... of the Ludwig Institute for Cancer Research (LICR...
...ice in field trials in China report higher crop yi...lated health problems, according to a study by res...e University of California, Davis. , Results of t...journal Science. , "This paper studies two of the ...oduction trials, the last step before commercializ...
Other Biology News:Multiple Campylobacter Genomes Sequenced 2Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy 2Genetically modified rice in China benefits farmers' health, study finds 2Genetically modified rice in China benefits farmers' health, study finds 3Genetically modified rice in China benefits farmers' health, study finds 4
IMAGEQUANT 400 WKSTN from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-Human IFN-Alpha / Beta R2 (IFNAR2) (CD118) Neutralizing Polyclonal Antibody, Unconjugated from PBL InterferonSource
Rabbit Anti-MYCOBACTERIUM TUBERCULOSIS Polyclonal Antibody, Unconjugated from AbD Serotec
ImageQuant 400 from GE Healthcare, formerly Amersham Biosciences
Biology Products: